Drug Price Transparency in Medicaid Act of 2023

Referred to the Subcommittee on Health.

• S 1038 Identical bill Drug Price Transparency in Medicaid Act of 2023
• HR 3561 PATIENT Act of 2023

• Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

• Energy and Commerce Committee
  House of Representatives
• Health Subcommittee
  House of Representatives · subcommittee of Energy and Commerce Committee

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

• THE KROGER CO.
  for KROGER CO · Ohio · 1st Quarter 2026 (Jan 1 - Mar 31)
• THE KROGER CO.
  for KROGER CO · Ohio · 4th Quarter 2025 (Oct 1 - Dec 31)
• THE METROHEALTH SYSTEM
  for THE METROHEALTH SYSTEM · Ohio · 4th Quarter 2025 (Oct 1 - Dec 31)
• THE METROHEALTH SYSTEM
  for THE METROHEALTH SYSTEM · Ohio · 4th Quarter 2025 (Oct 1 - Dec 31)
• THE METROHEALTH SYSTEM
  for THE METROHEALTH SYSTEM · Ohio · 3rd Quarter 2025 (July 1 - Sep 30)
• THE KROGER CO.
  for KROGER CO · Ohio · 3rd Quarter 2025 (July 1 - Sep 30)

Bodies those filers lobbied

• HOUSE OF REPRESENTATIVES
  12 filings
• SENATE
  12 filings
• Centers For Medicare and Medicaid Services (CMS)
  10 filings
• Health & Human Services, Dept of (HHS)
  6 filings
• Agriculture, Dept of (USDA)
  5 filings
• Environmental Protection Agency (EPA)
  5 filings
• Federal Trade Commission (FTC)
  5 filings
• Food & Drug Administration (FDA)
  5 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.